Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTBRJS9)

DTT Name	Inhibitory receptor SHPS-1 (SIRPA) DTT Info
Gene Name	SIRPA

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

3 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BI 765063	DMZMAOW	Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
CC-95251	DM7E1W0	Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]
FSI-189	DMPENAL	Non-hodgkin lymphoma	2B33.5	Phase 1	[3]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Clinical pipeline report, company report or official report of OSE Immunotherapeutics.
2	ClinicalTrials.gov (NCT03783403) A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPalpha, in Subjects With Advanced Solid and Hematologic Cancers. U.S. National Institutes of Health.
3	T cells bring unconventional cancer-targeting to the clinic - again. Nat Biotechnol. 2020 Apr;38(4):389-391.